Dr. Helen Patzanakidis, MD

Dr. Patzanakidis practices at Circle City Medical Group in Norco, California.

Dr. Patzanakidis' NPI, 1639288368, was assigned on August 29, 2006. Dr. Patzanakidis graduated from Ross University School of Medicine in 1993. Dr. Patzanakidis holds California license A83624.

Dr. Patzanakidis' primary practice is Circle City Medical Group, at 1901 Town & Country Dr, Norco, CA 92860 in Riverside County. The practice phone is (951) 737-8141.

Dr. Patzanakidis' primary practice is Circle City Medical Group in Norco, California. The medical group on file is Citrus Valley Medical Associates. Dmand AI also links Dr. Patzanakidis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patzanakidis practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Patzanakidis' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Patzanakidis' licenses on file in 3 states: California, New Jersey and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, acute mini-stroke (TIA), acute sinusitis, acute skin infection, ADHD, alzheimer's disease and anxiety among the conditions Dr. Patzanakidis treats.

CMS data shows 799 Medicare services from Dr. Patzanakidis across 9 procedure codes in 2024, for 201 Medicare patients. Medicare paid $61,841 for them. Every service was in an office.

CMS counts 201 Medicare patients who saw Dr. Patzanakidis in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patzanakidis' median patient age at 58, with 63% women.

In 2024, Dr. Patzanakidis wrote 10,751 Medicare Part D claims for 575 patients. 86% of them were for generic drugs. CMS names the drug for 10,077 of them, across 162 drugs with 11 or more claims each, at $852,783 in total drug cost. In 2023, CMS named 10,351 claims across 162 drugs.

Dr. Patzanakidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patzanakidis as offering telehealth. CMS counts 16 procedures of removal of skin lesions by Dr. Patzanakidis, more than 63% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 547 general payments to Dr. Patzanakidis from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,332.

Dmand AI lists 1 award for Dr. Patzanakidis, most recently CMS Stage 1 2012 in 2011.

Dr. Patzanakidis graduated from Ross University School of Medicine in 1993.

Dr. Patzanakidis is in network with 13 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.